Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Translational Research In Oncology

Clinical trials sponsored by Translational Research In Oncology, explained in plain language.

Drug combo vs standard therapy: which works better for liver cancer?

Disease control Terminated

This study aimed to compare two treatment approaches for intermediate-stage liver cancer that can't be cured surgically. It tested whether a combination of two cancer drugs (regorafenib and pembrolizumab) works better than standard liver-directed treatments (TACE or TARE). The tr…

Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC